Borson-Chazot Francoise, Borget Isabelle, Mathonnet Muriel, Leenhardt Laurence
Fédération d'Endocrinologie, Groupement Hospitalier Est, Hospices Civils de Lyon, Lyon, France; Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France.
Service de Biostatistiques et d'Epidémiologie, Direction de la Recherche Clinique, Gustave Roussy, Paris-Saclay University, 114 Rue Edouard Vaillant, Villejuif, France; Oncostat, Université Paris-Saclay U1018, Inserm, Université Paris-Saclay, Equipe labélisée "Ligue Contre le Cancer", Villejuif, France.
Ann Endocrinol (Paris). 2022 Dec;83(6):378-379. doi: 10.1016/j.ando.2022.10.003. Epub 2022 Oct 23.
The SFE-AFCE-SFMN 2022 consensus deals with the management of thyroid nodules, a condition that is a frequent reason for consultation in endocrinology. In more than 90% of cases, patients are euthyroid, with benign non-progressive nodules that do not warrant specific treatment. The clinician's objective is to detect malignant thyroid nodules at risk of recurrence and death, toxic nodules responsible for hyperthyroidism or compressive nodules warranting treatment. The diagnosis and treatment of thyroid nodules requires close collaboration between endocrinologists, nuclear medicine physicians and surgeons, but also involves other specialists. Therefore, this consensus statement was established jointly by 3 societies: the French Society of Endocrinology (SFE), French Association of Endocrine Surgery (AFCE) and French Society of Nuclear Medicine (SFMN); the various working groups included experts from other specialties (pathologists, radiologists, pediatricians, biologists, etc.). This section deals with epidemiology and challenges in the management of thyroid nodules.
《2022年SFE-AFCE-SFMN共识》涉及甲状腺结节的管理，甲状腺结节是内分泌科常见的会诊原因。在超过90%的病例中，患者甲状腺功能正常，有良性非进展性结节，无需特殊治疗。临床医生的目标是检测出有复发和死亡风险的恶性甲状腺结节、导致甲状腺功能亢进的毒性结节或需要治疗的压迫性结节。甲状腺结节的诊断和治疗需要内分泌科医生、核医学医生和外科医生密切合作，但也涉及其他专科医生。因此，本共识声明由3个学会联合制定：法国内分泌学会（SFE）、法国内分泌外科学会（AFCE）和法国核医学学会（SFMN）；各工作组包括来自其他专科（病理学家、放射科医生、儿科医生、生物学家等）的专家。本节讨论甲状腺结节管理中的流行病学和挑战。
Zotero 插件